Tandem Colonoscopy Study of Narrow Band Imaging Versus White Light Examination to Compare Neoplasia Miss Rates

Trial Information

Tandem Colonoscopy Study of Narrow Band Imaging Versus White Light Examination to Compare Neoplasia Miss Rates

This is a clinical study to evaluate whether the use of a new type of colonoscope may
improve the detection of colon polyps. Though colonoscopy is currently the best test for
colon cancer screening, it remains imperfect. Research has found that about 25% of polyps
may actually be missed during colonoscopy using standard full spectrum white light imaging.
Advances in colonoscopic technology hold the potential to decrease the miss rate of
colorectal neoplasms. A new colonoscope uses narrow band imaging, whereby the colon is
illuminated using only a subset of the white light spectrum, 415nanometers (blue) and 540
nanometers (green) rather than the standard full spectrum white light (red, green and blue).
Initial studies by other groups suggest that these narrow band images highlight small blood
vessels of colon polyps. As such, we hypothesized that the use of NBI would improve the
identification of neoplasms through the color differentiation of precancerous or cancerous
polyp (appearing brown) from normal colon mucosal lining (appearing green), and potentially
lead to a reduction in polyp miss rate. We aimed to study the polyp miss rate, and compare
narrow band imaging to white light examination.